In summary, this report demonstrates that Tr1 cells, not only cTreg cells, are present at the tumor site in the early stages of the tumor development and that the disruption of the CD49b/CD29 axis prevents tumor growth by at least targeting CD4+T and CD8+T cells function. The gene discussed is ITGA2; the disease is neoplasm.